Rusnano Invests In Bind, Selecta | Chemical & Engineering News
Volume 89 Issue 45 | p. 13 | Concentrates
Issue Date: November 7, 2011

Rusnano Invests In Bind, Selecta

Department: Business
Keywords: nanotechnology, Russia, biotechnology

Continuing its recent biotech investment spree, Russian Corporation of Nanotechnologies has invested a total of $50 million in the nanomedicine-based companies Bind Biosciences and Selecta Biosciences. Including contributions from other new and current investors, the two Boston-area firms have raised a total of $94.5 million in this funding round. Both firms use technologies originating at Harvard Medical School and MIT. As part of the Rusnano deal, Bind and Selecta are setting up subsidiaries in Russia to advance their technologies and to access scientific expertise, clinical-trial resources, manufacturing capabilities, and markets.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment